Pfizer to keep 350 jobs at U.K. center; Patent reform bill clears U.S. House;

@FiercePharma: Abbott pushes back closure date on Canadian plant. News | Follow @FiercePharma

> Pfizer will retain about 350 jobs at the site of its doomed U.K. research center in Sandwich, officials announced. Report

> Patent legislation that aims to clear a years-long backlog of applications and allows the patent office set its own fees was approved by the U.S. House of Representatives. News

> Texas Attorney General Greg Abbott filed a deceptive trade practices action against GlaxoSmithKline, claiming the British drugmaker falsely represented the quality of its Kytril, Bactroban, Paxil and Avandamet drugs. Article

> Mylan Pharmaceuticals is set to launch its version of the AstraZeneca Crohn's disease drug Entocort in the U.S. following a victory in a patent litigation case. Story

> Pfizer's board declared a 20-cent dividend for the third quarter, to be paid September 6 to shareholders as of August 5. Pfizer release

> A side effect of many commonly used drugs, including antihistamines and antidepressants: They appear to increase the risk of reduced brain function and early death in older people, a study showed. Item

Biotech News

@FierceBiotech: BMS, AZ diabetes drug will face scrutiny. Item | Follow @FierceBiotech

@JohnCFierce: At a Rothschild conference in Cap Ferrat. Remark by Claus Baestrap (former Lundbeck CEO): In-licensed programs do better than in-house. Follow @JohnCFierce

> FDA shoots down Pfizer, Pain Therapeutics drug. Story 

> Roche, Evotec partner on oncology biomarkers. Item 

And Finally... Nearly a dozen people in Washington state and Montana who had contact with infected goats have been diagnosed with Q fever, a disease common among livestock but rare in humans. Report